109 related articles for article (PubMed ID: 7617069)
21. Protease and antiprotease concentrations in serum and vaginal fluid of patients with carcinoma of the cervix.
Benítez-Bribiesca L; Freyre-Horta R; Gallegos-Vargas G
Arch Invest Med (Mex); 1980; 11(4):523-45. PubMed ID: 7011240
[TBL] [Abstract][Full Text] [Related]
22. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
Lee JM; Lee KB; Lee SK; Park CY
J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
[TBL] [Abstract][Full Text] [Related]
23. Increased cathepsin B activity in human lung tumors.
Krepela E; Kasafírek E; Novák K; Viklický J
Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
[TBL] [Abstract][Full Text] [Related]
24. [Indications and results of extemporaneous examination of pelvic lymph nodes in the surgical strategy of stage Ib or II cancers of the cervix uteri].
Morice P; Sabourin JC; Pautier P; Mercier S; Duvillard P; Castaigne D
Ann Chir; 1999; 53(7):583-6. PubMed ID: 10520497
[TBL] [Abstract][Full Text] [Related]
25. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
26. Cytoenzymologic investigations on carcinomas of the cervix uteri.
Duţu R; Nedelea M; Veluda G; Burculeţ V
Acta Cytol; 1980; 24(2):160-6. PubMed ID: 6929150
[TBL] [Abstract][Full Text] [Related]
27. Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease.
Tsai HT; Wang PH; Tee YT; Lin LY; Hsieh YS; Yang SF
Fertil Steril; 2009 Feb; 91(2):549-55. PubMed ID: 18314113
[TBL] [Abstract][Full Text] [Related]
28. [Cytofluorimetric research on the epithelium of the cervix uteri in malignancy].
Ganina KP; Nosa PP; Boroda AN; Klevetenko MP
Tsitol Genet; 1993; 27(2):30-7. PubMed ID: 8212323
[TBL] [Abstract][Full Text] [Related]
29. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
30. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
[TBL] [Abstract][Full Text] [Related]
31. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
[TBL] [Abstract][Full Text] [Related]
32. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
34. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers.
Herszényi L; István G; Cardin R; De Paoli M; Plebani M; Tulassay Z; Farinati F
Eur J Cancer Prev; 2008 Oct; 17(5):438-45. PubMed ID: 18714186
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
[TBL] [Abstract][Full Text] [Related]
36. Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression.
Miyake H; Hara I; Eto H
Anticancer Res; 2004; 24(4):2573-7. PubMed ID: 15330217
[TBL] [Abstract][Full Text] [Related]
37. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
38. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
39. Serum proteinase levels, platelet functional and morphological alterations in patients with cervix uteri carcinoma. Correlation with the degree of progression of the malignancy.
Benítez-Bribiesca L; Villanueva C; Freyre R; Amezcua JL; de la Huerta R; Luévano E; Pastrana L
Arch Invest Med (Mex); 1986; 17(2):211-42. PubMed ID: 3109344
[No Abstract] [Full Text] [Related]
40. Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri.
Horn LC; Hentschel B; Galle D; Bilek K
Gynecol Oncol; 2008 Jan; 108(1):63-7. PubMed ID: 17920109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
